Investing in ProShares Ultra Nasdaq Biotechnology? If so, we recommend checking out these offers as well (we believe these to be much more interesting):
Cannabis Trader: https://logistics-business-review.com/cannabis-trader-for-BIB-investors
Trade Netflix: https://logistics-business-review.com/netflix-for-BIB-investors
Wall Street Journal: https://logistics-business-review.com/wsj-for-BIB-investors (only $12 for 12 weeks – everyone should get this)
REPORTING FOR 2019-07-29 | LOGISTICS-BUSINESS-REVIEW.COM: We have conducted a deep analysis of how ProShares Ultra Nasdaq Biotechnology ($BIB) has been trading over the last 2 weeks and the past day especially. On its latest session, ProShares Ultra Nasdaq Biotechnology ($BIB) opened at 47.33, reaching a high of 48.09 and a low of 47.0 before closing at a price of 48.04. There was a total volume of 96990.
VOLUME INDICATORS: We saw an accumulation-distribution index of 2757.12395, an on-balance volume of 47.21, chaikin money flow of 1.86842 and a force index of 0.023. There was an ease of movement rating of -0.00044, a volume-price trend of -2.64792 and a negative volume index of 1000.0.
VOLATILITY: We noted an average true range of 1.23689, bolinger bands of 47.19142, an upper bollinger band of 46.90858, lower bollinger band of 47.0, a bollinger high band indicator of 1.0, bollinger low band indicator of 1.0, a central keltner channel of 47.47333, high band keltner channel of 46.71333, low band keltner channel of 48.23333, a high band keltner channel indicator of 1.0 and a low band keltner channel indicator of 1.0. There was a donchian channel high band of 47.0, a donchian channel low band of 47.0, a donchian channel high band indicator of 1.0, and a donchian channel low band indicator of 1.0.
TREND: We calculated a Moving Average Convergence Divergence (MACD) of 0.00224, a MACD signal of 0.00125, a MACD difference of 0.001, a fast Exponential Moving Average (EMA) indicator of 47.0, a slow Exponential Moving Average (EMA) indicator of 47.0, an Average Directional Movement Index (ADX) of unknown, an ADX positive of 20.0, an ADX negative of 20.0, a positive Vortex Indicator (VI) of 1.0, a negative VI of 1.0, a trend vortex difference of 0.09654, a trix of -3.08727, a Mass Index (MI) of 1.0, a Commodity Channel Index (CCI) of 66.66667, a Detrended Price Oscillator (DPO) of 2.80954, a KST Oscillator (KST) of -56.40576 and a KST Oscillator (KST Signal) of -56.40576 (leaving a KST difference of 0.50191). We also found an Ichimoku rating of 47.71, an Ichimoku B rating of 47.71, a Ichimoku visual trend A of 50.58042, an Ichimoku visual trend B of 49.99825, an Aroon Indicator (AI) up of 4.0 and an AI indicator down of 4.0. That left a difference of 4.0.
MOMENTUM: We found a Relative Strength Index (RSI) of 50.0, a Money Flow Index (MFI) of 49.76361, a True Strength Index (TSI) of -100.0, an ultimate oscillator of -63.38886, a stochastic oscillator of 143.42105, a stochastic oscillator signal of 143.42105, a Williams %R rating of 43.42105 and an awesome oscillator of 0.13046.
RETURNS: There was a daily return of -5.64058, a daily log return of 0.21254 and a cumulative return of 0.21277.
What the heck does all of this mean? If you are new to technical analysis, the above may be gibberish to you, and that’s OK (though we do advise learning these things). The bottom line is that AS OF 2019-07-29 (if you are reading this later, the analysis will be out of date), here is what our deep analysis of technical indicators are telling us for ProShares Ultra Nasdaq Biotechnology ($BIB)…
For a more complete analysis, run all of this through the BTMA software. Also, to stay up to date with what is happening on ProShares Ultra Nasdaq Biotechnology, we strongly advise ProShares Ultra Nasdaq Biotechnology investors to subscribe to MarketBeat.com’s daily email newsletter for updates, news and analyst ratings on stocks like ProShares Ultra Nasdaq Biotechnology – without this you are trading blind:
We will of course continue to cover the news and price action of ProShares Ultra Nasdaq Biotechnology, but it’s easiest for you to just subscribe to MarketBeat’s newsletter above so you don’t miss anything.
DISCLAIMER: We are not registered investment advisers and the above analysis should be taken at face value only. We strongly advise against buying or selling ProShares Ultra Nasdaq Biotechnology ($BIB) based solely on our analysis above, and are not responsible for any losses that you may incur if you choose make any investment decisions based on the above.
Latest posts by Gary Ivenchuck (see all)
- What’s Better: Alliant Energy Corporation ($LNT) or VivoPower International PLC ($VVPR) - August 20, 2019
- The Battle Of MTech Acquisition Corp. ($MTECU) And AGM Group Holdings Inc. ($AGMH) - August 20, 2019
- Apollo Medical Holdings, Inc. ($AMEH) Takes On China Internet Nationwide Financial Services Inc. ($CIFS) - August 20, 2019